You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API NAFTIFINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing NAFTIFINE HYDROCHLORIDE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Merz Pharmaceuticals LLC NAFTIN naftifine hydrochloride 0259-4126 BENZYL ALCOHOL
Merz Pharmaceuticals LLC NAFTIN naftifine hydrochloride 0259-4126 CETYL ALCOHOL
Merz Pharmaceuticals LLC NAFTIN naftifine hydrochloride 0259-4126 CETYL ESTERS WAX
Merz Pharmaceuticals LLC NAFTIN naftifine hydrochloride 0259-4126 ISOPROPYL MYRISTATE
Merz Pharmaceuticals LLC NAFTIN naftifine hydrochloride 0259-4126 POLYSORBATE 60
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing NAFTIFINE HYDROCHLORIDE

Company Ingredient NDC Excipient
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1510 ALCOHOL
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1510 CARBOMER HOMOPOLYMER TYPE B
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1510 DIISOPROPANOLAMINE
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1510 EDETATE DISODIUM
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1510 POLYSORBATE 80
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for NAFTIFINE HYDROCHLORIDE

Excipient focus: ALCOHOL

Excipient focus: BENZYL ALCOHOL

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CETYL ALCOHOL

Excipient focus: CETYL ESTERS WAX

Excipient focus: DIISOPROPANOLAMINE

Excipient focus: EDETATE DISODIUM

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

NAFTIFINE HYDROCHLORIDE drug variants not containing HYDROXYETHYL CELLULOSE

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1510
Amneal Pharmaceuticals of New York LLC naftifine hydrochloride 0115-1512
Merz Pharmaceuticals LLC naftifine hydrochloride 0259-4126
Renaissance Pharma Inc naftifine hydrochloride 40085-203
Taro Pharmaceuticals USA Inc naftifine hydrochloride 51672-1362
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ISOPROPYL MYRISTATE

Excipient focus: POLYSORBATE 20

Excipient focus: POLYSORBATE 60

Excipient focus: POLYSORBATE 80

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SORBITAN MONOSTEARATE

Excipient focus: STEARYL ALCOHOL

Excipient focus: TROLAMINE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group